Söndag 23 Februari | 22:27:51 Europe / Stockholm

Prenumeration

2025-02-17 08:28:00

Redeye updates its view on Genovis following the company's year-end report. While we make slight downward revisions to our estimates, we note that the share continues to trade near our bear case levels despite continued growth and expanding margins in the analytics business.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/